Aquaphor Itch Relief Ointment
NDC Package 10356-120-07
Package Information
Aquaphor Itch Relief (hydrocortisone) ointment is a medication used to treat a variety of skin conditions (e.g., insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). This formulation utilizes a ointment delivery system. Marketed by Beiersdorf Inc, this product is identified by NDC 10356-120 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 203105 - hydrocortisone 1 % Topical Ointment
- RxCUI: 203105 - hydrocortisone 0.01 MG/MG Topical Ointment
- RxCUI: 2462510 - Aquaphor Itch Relief 1 % Topical Ointment
- RxCUI: 2462510 - hydrocortisone 0.01 MG/MG Topical Ointment [Aquaphor Itch Relief]
- RxCUI: 2462510 - Aquaphor Itch Relief 0.01 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 10356 - Beiersdorf Inc
- 10356-120 - Aquaphor Itch Relief
- 10356-120-07 - 56 g in 1 TUBE
- 10356-120 - Aquaphor Itch Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (10356-120). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 10356-120-07 identifies a specific commercial package of 56 g in 1 tube of Aquaphor Itch Relief, a human over the counter drug labeled by Beiersdorf Inc. This ointment is formulated for topical use and contains hydrocortisone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Beiersdorf Inc on November 01, 2020. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a variety of skin conditions (e.g., insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid.
How is this Beiersdorf Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 10356012007. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
